# data[].attributes.body
A single, wireless patch with 5 electrodes and a monitoring device  that is placed on a woman's gravid abdomen to monitor fetal heart rate, contractions, and maternal heart rate during labor and delivery.

# data[].attributes.headline
"FDA Clears Monica's Wireless Fetal Heart Rate Monitor" Article

# data[].attributes.subject
"FDA Clears Monica's Wireless Fetal Heart Rate Monitor" Article

# data[].attributes.attachment_link.readable_text
Last week the US Food and Drug Administration (FDA) granted 510(k) clearance for UK-based Monica Healthcare's AN24 wireless fetal monitor for use during labor and delivery. The clearance allows AN24 to be used for intrapartum term monitoring for all singleton births in the US, according to the company.

"The Monica AN24 uses innovative wireless, non-invasive technology to collect real-time electrical signals from the abdomen of a pregnant mother," the company stated in a press release. "The device uses complex algorithms to correctly identify signals related to the fetal heart rate and uterine muscle (contraction signals) on the abdomen of singleton pregnant women using ECG-style electrodes. This method of using electrophysiological signals differs from current external monitoring devices that collect FHR and uterine activity data based on physical changes (e.g. change in reflected sound waves and changes on strain gauge) that may cause problems in data interpretation such as discerning FHR vs. MHR data."

Interestingly, Monica points out that clinical trials in the US demonstrated that Monica performs well for obese pregnant women.

"We found the Monica AN24 performed excellently in very obese women (BMI >35) when compared with available Doppler ultrasound/tocodynamometer techniques," Professor W. Cohen of Albert Einstein College of Medicine, New York stated in the press release. Conventional external monitoring is sometimes challenging with obese women, according to the company, and obesity in pregnancy is becoming more prevalent as the obesity rate in general continues to surge in the US.

For hospital use cases, Monica's AN24 device will be sold exclusively through Glenveigh Medical and its distribution partner Norgenix in the US.

More on the FDA clearance in the press release after the jump.

8th February 2011

Monica Healthcare gains FDA clearance for groundbreaking wireless fetal monitor

Monica Healthcare (based in the UK), has announced that the US Food and Drug Administration (FDA) have granted regulatory clearance of their Monica AN24 wireless fetal monitor for use during Labour and Delivery. This FDA clearance enables Monica technology to be utilised for intrapartum term monitoring for all singleton births in the USA.

The Monica AN24 uses innovative wireless, non-invasive technology to collect real-time electrical signals from the abdomen of a pregnant mother. The device uses complex algorithms to correctly identify signals related to the fetal heart rate and uterine muscle (contraction signals) on the abdomen of singleton pregnant women using ECG-style electrodes. This method of using electrophysiological signals differs from current external monitoring devices that collect FHR and uterine activity data based on physical changes (e.g. change in reflected sound waves and changes on strain gauge) that may cause problems in data interpretation such as discerning FHR vs. MHR data .

The Monica AN24 is simple to use, beltless, requires no wires to connect to the display or printer, and will provide high levels of patient satisfaction. There is also no need for the constant re-positioning of transducers, which is required with the current technology, especially during an epidural when the patient is on her side. Clinical trials in the US also have demonstrated that Monica performs well in obese women. Professor W. Cohen from Albert Einstein College of Medicine, New York, stated: "We found the Monica AN24 performed excellently in very obese women (BMI >35) when compared with available Doppler ultrasound/tocodynamometer techniques." Obesity in pregnancy is becoming more prevalent and acquiring accurate FHR and uterine activity signals in obese patients using conventional external monitoring is sometimes challenging.

Carl Barratt, CEO of Monica Healthcare, explained "the introduction of Monica AN24 to the US market is a significant milestone for Monica Healthcare, an endorsement of the team here, and represents an exciting opportunity for this advanced technology to positively impact the care of pregnant women during the critical stages of labour." Monica hopes that its technology will lead to improved patient care, raise efficiency, and ultimately reduce the cost of pregnancy care in the hospital

In the hospital, the Monica AN24 will be available exclusively in the USA through Glenveigh Medical. Glenveigh and its sales and distribution partner, Norgenix , will be promoting the device to pregnancy clinicians. It was formally introduced at the 31st meeting of the Society of Maternal-Fetal Medicine in San Francisco February 9-11.

For more information on Monica Healthcare, please visit www.monicahealthcare.com or contact info@monicahealthcare.com In the USA please contact Glenveigh Medical ( www.glenveigh.com) or Norgenix ( www.norgenixpharma.com).

# data[].attributes.attachment_link.title
FDA clears Monica's wireless fetal heart rate monitor

# data[].attributes.attachment_link.description
Last week the US Food and Drug Administration (FDA) granted 510(k) clearance for UK-based Monica Healthcare's AN24 wireless fetal monitor for use during labor and delivery. The clearance allows AN24 to be used for intrapartum term monitoring for all singleton births in the US, according to the company.

# data[].attributes.body
Company:  Monica Healthcare
http://www.monicahealthcare.com
(Photos retrieved from Monica website)

Electronic Fetal Monitor photo retrieved from http://www.moondragon.org/obgyn/pregnancy/fetalassesschart.html

# data[].attributes.body
>Women can be mobile throughout labor.
>No re-positioning of monitors/belts required.
>Can be used on high BMI patients (35<BMI<60).
>Waterproof- can be used while women take baths/shower for labor comfort.
>Minimizes risk for maternal and fetal heart rate confusion
>More comfortable
>Antepartum Monitoring- women can sleep without interruptions and use the bathroom without assistance.
>System cannot be incorrectly placed and pairs automatically to monitoring system

# data[].attributes.body
>Learning curve for hospital staff.
>Initial expense for hospital over traditional methods of fetal monitoring.
>More intensive patient education and apprehension over new technology.

# data[].attributes.body
As a Labor & Delivery RN, my co-workers and I have been waiting for a piece of technology like this for our patients with high BMIs.  Often times, women are "stuck in  bed", strapped down to monitors during labor, and the nurses must constantly adjust the fetal monitors with each position change.  Putting the Novii Wireless Patch System to use at work will allow our patients to be more mobile during external fetal monitoring, and will reduce the risk for error during monitoring (ex. tracing maternal heart rate instead of fetal heart rate).

Now that this new invention is being used on actual patients in L&D units, the entire experience will change for the better, for both patients and their families, and hospital staff!

# data[].attributes.headline
Video of Novii Training Sessions (complete version)

# data[].attributes.subject
Video of Novii Training Sessions (complete version)